3301 - 3350 of 8142 Results
Title
Year
- Bayesian estimation of cell type–specific gene expression with prior derived from single-cell data2021OPENTitle: Bayesian estimation of cell type–specific gene expression with prior derived from single-cell dataJournal Name: Genome ResearchPublisher: Cold Spring Harbor LaboratoryVol: 31Issue #: 10Start Page: 1807End Page: 1818Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1101/gr.268722.120Best OA location URL: https://genome.cshlp.org/content/31/10/1807.full.pdfCitation Count: 65
-
OPENTitle: Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a C. elegans model of Parkinson’s diseaseJournal Name: Medicinal Chemistry ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 5Start Page: 1166End Page: 1174Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00044-021-02720-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570587Citation Count: 2
-
OPENTitle: Gene-Environment Interactions in Progressive Supranuclear PalsyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.664796Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.664796/pdfCitation Count: 1
-
OPENTitle: Accumulation of Brain Hypointense Foci on Susceptibility-Weighted Imaging in Childhood Ataxia TelangiectasiaJournal Name: American Journal of NeuroradiologyPublisher: American Society of Neuroradiology (ASNR)Vol: 42Issue #: 6Start Page: 1144End Page: 1150Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3174/ajnr.a7107Best OA location URL: http://www.ajnr.org/content/ajnr/42/6/1144.full.pdfCitation Count: 5
-
RESTRICTEDTitle: Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the RescueJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.673205Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.673205/pdfCitation Count: 23
-
OPENTitle: Corneal Confocal Microscopy Identifies Parkinson's Disease with More Rapid Motor ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1927End Page: 1934Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28602Best OA location URL: https://doi.org/10.1002/mds.28602Citation Count: 22
-
OPENTitle: Subcortical short‐term plasticity elicited by deep brain stimulationJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 5Start Page: 1010End Page: 1023Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51275Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51275Citation Count: 27
-
OPENTitle: A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson’s Research and CareJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 905End Page: 908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212593Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212593?id=journal-of-parkinsons-disease%2Fjpd212593Citation Count: 22
-
RESTRICTEDTitle: Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson’s Disease: A Longitudinal Analysis of Two International CohortsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1209End Page: 1219Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-212570Citation Count: 27
-
OPENTitle: Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.648417Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.648417/pdfCitation Count: 10
- Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials2021RESTRICTEDTitle: Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical TrialsJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.648532Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.648532/pdfCitation Count: 21
-
OPENTitle: Hispanic Perspectives on Parkinson’s Disease Care and Research ParticipationJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 81Issue #: 2Start Page: 809End Page: 819Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jad-210231Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad210231?id=journal-of-alzheimers-disease%2Fjad210231Citation Count: 16
-
RESTRICTEDTitle: Prodromal Parkinson disease — time is brainJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 17Issue #: 6Start Page: 329End Page: 330Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-021-00489-6Citation Count: 1
-
RESTRICTEDTitle: The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient SelectionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 14Start Page: 664End Page: 676Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000011704Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105965Citation Count: 31
-
OPENTitle: Cognitive Profile and Markers of Alzheimer Disease–Type Pathology in Patients With Lewy Body DementiasJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 14Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000011699Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105963Citation Count: 41
-
OPENTitle: Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 5Start Page: 1122End Page: 1131Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51358Citation Count: 12
-
OPENTitle: Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central EuropeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 48End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.026Best OA location URL: http://manuscript.elsevier.com/S135380202100119X/pdf/S135380202100119X.pdfCitation Count: 12
- Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐Analysis2021RESTRICTEDTitle: Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1293End Page: 1307Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28599Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/238481/238481.pdfCitation Count: 20
-
RESTRICTEDTitle: ATP1A3-Related Disorders: An Ever-Expanding Clinical SpectrumJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.637890Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.637890/pdfCitation Count: 32
-
OPENTitle: Cerebello‐Cortical Control of Tremor Rhythm and Amplitude in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1727End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28603Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/238510/238510.pdfCitation Count: 30
-
OPENTitle: Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platformsJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/jev2.12079Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12079Citation Count: 139
- Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments2021RESTRICTEDTitle: Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New TreatmentsJournal Name: Archives of Medical ResearchPublisher: Elsevier BVVol: 52Issue #: 3Start Page: 243End Page: 251Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arcmed.2020.10.021Citation Count: 25
-
RESTRICTEDTitle: Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysisJournal Name: CancerPublisher: WileyVol: 127Issue #: 14Start Page: 2409End Page: 2422Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cncr.33516Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.33516Citation Count: 75
-
OPENTitle: Evidence forGRNconnecting multiple neurodegenerative diseasesJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab095Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/2/fcab095/41728465/fcab095.pdfCitation Count: 33
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://repositorio.uca.edu.ar/bitstream/123456789/11645/6/fluoxetine-symptomatic-treatment-atrophy%20%281%29.pdfCitation Count: 20
-
RESTRICTEDTitle: Genetic updates on paroxysmal dyskinesiasJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 128Issue #: 4Start Page: 447End Page: 471Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-021-02335-xCitation Count: 8
-
OPENTitle: Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor SubtypesJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000557Best OA location URL: https://ng.neurology.org/content/nng/7/2/e557.full.pdfCitation Count: 34
-
RESTRICTEDTitle: Intersection of immunometabolism and immunosenescence during agingJournal Name: Current Opinion in PharmacologyPublisher: Elsevier BVVol: 57Issue #:Start Page: 107End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.coph.2021.01.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481958Citation Count: 21
-
RESTRICTEDTitle: Mindfulness based stress reduction in people with Parkinson's disease and their care partnersJournal Name: Complementary Therapies in Clinical PracticePublisher: Elsevier BVVol: 43Issue #:Start Page: 101377End Page: 101377Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ctcp.2021.101377Citation Count: 11
-
OPENTitle: Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozinJournal Name: NeoplasiaPublisher: Elsevier BVVol: 23Issue #: 4Start Page: 391End Page: 399Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neo.2021.02.003Best OA location URL: https://doi.org/10.1016/j.neo.2021.02.003Citation Count: 16
-
OPENTitle: Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette SyndromeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 694End Page: 700Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13207Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13207Citation Count: 6
-
OPENTitle: Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab109Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/2/fcab109/41723515/fcab109.pdfCitation Count: 33
-
OPENTitle: Variable number tandem repeats – Their emerging role in sickness and healthJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 246Issue #: 12Start Page: 1368End Page: 1376Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1177/15353702211003511Best OA location URL: https://doi.org/10.1177/15353702211003511Citation Count: 17
-
OPENTitle: Will Artificial Intelligence Outperform the Clinical Neurologist in the Near Future? NoJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 4Start Page: 529End Page: 531Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13200Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13200Citation Count: 2
-
RESTRICTEDTitle: Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 8Start Page: 3641End Page: 3652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02371-4Citation Count: 13
-
OPENTitle: Pervasive cis effects of variation in copy number of large tandem repeats on local DNA methylation and gene expressionJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 108Issue #: 5Start Page: 809End Page: 824Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2021.03.016Best OA location URL: http://www.cell.com/article/S0002929721001002/pdfCitation Count: 33
-
OPENTitle: Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity studyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2101Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119826Citation Count: 13
-
RESTRICTEDTitle: Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the StriatumJournal Name: Clinical Nuclear MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 46Issue #: 6Start Page: e296End Page: e306Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/rlu.0000000000003609Citation Count: 3
-
OPENTitle: Lipidomics Prediction of Parkinson’s Disease Severity: A Machine-Learning AnalysisJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1141End Page: 1155Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-202476Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355022Citation Count: 29
-
OPENTitle: Palliative Care and Parkinson's Disease: Time to Move Beyond CancerJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1325End Page: 1329Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28556Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217287Citation Count: 17
- Tablet-based patient educational interventions in care and management of complex movement disorders2021RESTRICTEDTitle: Tablet-based patient educational interventions in care and management of complex movement disordersJournal Name: Disability and Rehabilitation: Assistive TechnologyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 627End Page: 634Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17483107.2021.1900934Citation Count: 2
-
OPENTitle: Association of Mitochondrial DNA Genomic Variation With Risk of Pick DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000011649Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055308Citation Count: 2
-
OPENTitle: Tau induces formation of α-synuclein filaments with distinct molecular conformationsJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 554Issue #:Start Page: 145End Page: 150Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2021.03.091Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062303Citation Count: 23
-
RESTRICTEDTitle: Public Engagement and Neurology: An UpdateJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 4Start Page: 429End Page: 429Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11040429Best OA location URL: https://www.mdpi.com/2076-3425/11/4/429/pdf?version=1617937511Citation Count: 5
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/bitstream/123456789/11625/1/effects-angiotensin-1-type-receptor.pdfCitation Count: 11
-
RESTRICTEDTitle: Magnetic resonance imaging quality control, quality assurance and quality improvementJournal Name: Pediatric RadiologyPublisher: Springer Science and Business Media LLCVol: 51Issue #: 5Start Page: 698End Page: 708Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00247-021-05043-6Citation Count: 8
-
OPENTitle: Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.645706Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.645706/pdfCitation Count: 20
- ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation system2021OPENTitle: ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation systemJournal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 9Start Page: 2013End Page: 2030.e9Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.03.001Best OA location URL: http://www.cell.com/article/S1097276521001696/pdfCitation Count: 66
- Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursing2021RESTRICTEDTitle: Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursingJournal Name: Archives of Psychiatric NursingPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 284End Page: 289Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.apnu.2021.03.006Citation Count: 6
-
RESTRICTEDTitle: Obtaining Objective Clinical Measures During Telehealth Evaluations of DysarthriaJournal Name: American Journal of Speech-Language PathologyPublisher: American Speech Language Hearing AssociationVol: 30Issue #: 2Start Page: 503End Page: 516Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1044/2020_ajslp-20-00243Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740561Citation Count: 16